Clinician Investigator, Cancer Research
Ottawa Hospital Research Institute

Clinical Interest:

Breast and Gynecologic Oncologic Surgical Pathology
Cytopathology

EXECUTIVE SUMMARY:
Dr. Islam's illustrious career in pathology and healthcare spans over 20 years, with a current position as Associate Professor in the Faculty of Medicine at the University of Ottawa. His impact is felt nationally and internationally through his exceptional contributions to clinical practice, teaching, and research.

NATIONAL AND INTERNATIONAL IMPACT:
Dr. Islam's influence in pathology extends beyond the borders of Canada, making him a distinguished figure on both national and international fronts. His leadership roles and contributions to various committees have significantly shaped the field of Cytopathology at the national level.

NATIONAL LEVEL:At the national level, Dr. Islam has been instrumental in the establishment and advancement of the "Area of Focus Competence (AFC) in Cytopathology" diploma program at the Royal College of Physicians and Surgeons of Canada (RCPSC). His role as the Chair of the AFC Cytopathology Specialty Committee solidifies his position as a national leader. His participation in the CanMEDS 2024 Working Group reflects his influence in broadening the definition of crucial roles in healthcare, impacting future generations of physicians.Dr. Islam's impact extends to quality improvement, where he chaired the Cytopathology Scientific Committee at the Institute of Quality Management in Healthcare (IQMH), contributing to the development of "Best Practice Recommendation Guidelines for Gynecologic and Non-Gynecologic Cytopathology." His involvement in the National meeting of Specialty Chairs at RCPSC demonstrates his commitment to excellence across diverse medical disciplines.His commitment to quality assessment is evident through his roles as an Assessor for Pathology by the College of Physicians and Surgeons of Ontario (CPSO) and IQMH, actively contributing to the improvement of healthcare services and standards.Locally, Dr. Islam has significantly impacted diagnostic oncology at The Ottawa Hospital, holding key positions such as Director of Cytopathology and Deputy Head and Site-Chief for anatomical pathology. His leadership roles emphasize the expansion of clinical services and the enhancement of patient care quality.

INTERNATIONAL LEVEL:On the international stage, Dr. Islam's impact is profound. His active participation in 53 prestigious international events, including renowned congresses and conferences, showcases his commitment to advancing knowledge globally. Invitations to speak at international conferences highlight his esteemed status and the demand for his insights.Dr. Islam's contributions to academic literature, including peer-reviewed publications in prestigious journals and authorship of 43 chapters on PathologyOutlines.com, solidify his reputation as a distinguished authority in Pathology and Laboratory Medicine globally.His recognition as a podcast guest on the International Society of Gynecological Pathologists' (ISGyP) LiVE series reflects his commitment to innovative discussions and knowledge dissemination. Invitations as an Expert External Assessor for the Kingdom of Saudi Arabia's Anatomical Pathology Program and engagements with the Pathology Society of Saudi Arabia underscore his international impact.

EDUCATION AND RESEARCH CONTRIBUTIONS:
Dr. Islam's dedication to education is exemplified by his decade-long service as the Residency Program Director for Anatomical Pathology at the University of Ottawa. As a Clinician Investigator at the Ottawa Hospital Research Institute (OHRI), his research activities contribute to the advancement of pathology knowledge.

TEACHING:
Dr. Islam's impact as an educator is profound, extending beyond clinical and research contributions. As the Residency Program Director for Anatomical Pathology at the University of Ottawa, he has played a pivotal role in shaping a supportive educational environment. His national contributions to education include active involvement in developing Competence by Design (CBD) documents for residency training.Internationally, Dr. Islam's commitment to education knows no bounds. His mentorship of international fellows and advocacy for International Medical Graduates (IMGs) integration in Canada demonstrates his dedication to fostering diversity within the healthcare workforce.As the Program Director in Anatomical Pathology, Dr. Islam's influence on resident physicians is evident in their success, with many pursuing specialized training and achieving academic promotions. His commitment to research and teaching excellence is reflected in his mentorship of residents and active involvement in clinical trials.In conclusion, Dr. Islam's impact in clinical practice, teaching, and research transcends national and international boundaries. His leadership, expertise, and commitment to excellence have left an indelible mark on the healthcare community, solidifying his position as a prominent figure in the field of pathology and healthcare worldwide.

PUBLICATIONS:

Peer Reviewed Published Manuscripts, Commentaries, Practice Guidelines and Book Chapters

1. Area of focused competence in cytopathology: An empowered version of fellowship training in cytopathology in Canada. Islam et. al. Canadian Journal of Pathology (November 2021), Volume 13, Issue 4, www.cap-acp.org

2. Combination of MCM2 with Ki67 and P16 Immunohistochemistry Can Distinguish Uterine Leiomyosarcomas. Keyhanian, Kianoosh; Lage, Janice M. ; Chernetsova, Elizaveta ; Sekhon, Harman; Eslami; Zohreh, Islam, Shahidul (author of correspondence). International Journal of Gynecological Pathology: (June 05, 2019), Volume Publish Ahead of Print - Issue - https://journals.lww.com/intjgynpathology/Abstract/publishahead/Combination_of_MCM2_With_Ki67_and_p16.99091.aspx

3. IFITM1 Outperforms CD10 in Differentiating Low Grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus. Aurelia Busca, Carlos Parra-Herran, Previn Gulavita, Shahidul Islam (author of correspondence). International Journal of Gynecological Pathology, Volume 37, Issue 4, (July 2018), pp. 372-378(7).

4. Combination of cyclin-D1 and MCM2 immunohistochemistry can reliably distinguish uterine leiomyosarcomas. Keyhanian, Kianoosh; Lage, Janice; Chernetsova, Elizaveta; Eslami, Zohreh; Islam, Shahid (author of correspondence). Canadian Journal of Pathology. 2018 Supplement, Vol. 10, p43-43. 1/2p.

5. Histomorphological Changes in Endometriosis in a Patient Treated with Ulipristal: A Case Report. Justin Batemen and Shahidul Islam (author of correspondence). Pathology - Research and Practice Volume 213, Issue 1, (January 2017), Pages 79-81.

6. Architectural Overlap Between Benign Endocervix and Pattern-A Invasive Endocervical Adenocarcinoma: Are All Pattern-A Tumors Invasive? Greg Douglas, Brooke E Howitt, John Schoolmeester, Lauren Schwartz, Zuzana Kos, Shahidul Islam, Bojana Djordjevic, Carlos Parra-Herran. Pathol Res Pract. (2017 July), 213(7): 799-803.

7. Nuclear Immunohistochemical IKK-Eexpression in Flat Epithelial Atypia (FEA) of the Breast: A Predictor of Ipsilateral ADH, In-Situ or Invasive Malignancy? PA Williams, CE Parra-Herran, Y Ayroud, S Islam, DH Gravel, SJ Robertson, C Pratt, Cancer Research, (February 2015), Volume, 76, Issue 4, Pages 01-11.

8. GATA-3 Expression is not Associated with Complete Pathological Response in Triple Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
J. K. Wasserman, P. A. Williams, S. Islam, S. J. Robertson. Pathology - Research and Practice Volume 212, Issue 6, (June 2016), Pages 539-544.

9. Incidental Endometrial Carcinoma Diagnosed at First Trimester Pregnancy Loss – Case Report and Discussion. L. Saciragic, C. Ball, S. Islam, M. Fung Kee Fung. J Obstet Gynaecol Can. (2014), 36(11): 1010-1013.

10. Three-Dimensional Cell Groups with Disordered Nuclei and Cellular Discohesion (3DDD) are Associated with High Sensitivity and Specificity for Cystoscopic Urine Cytopathological Diagnosis of Low-Grade Urothelial Neoplasia. Mai KT, Ball CG, Kos Z, Belanger EC, Islam S, Sekhon H. Diagn Cytopathol. (2014 Jul), 42(7):555-63. doi: 10.1002/dc.23069. Epub 2013 Nov 23.

11. Teaching the Can MEDS Roles to Laboratory Medicine Residents: Residents as Teachers and Development of ePortfolios. S. Strickland and S. Islam (author of correspondence). Canadian Journal of Pathology, (Fall 2014), Volume 6, Issue 3, Page 80-85.

12. A Historical Step for Advanced Cytopathology Training in Canada.
S. Islam, M. Wier and M. Auger (all authors contributed equally). Cancer Cytopath. (January 2015), Volume 123, Issue 1, Pages 7-9.

13. Nuclear Morphometry in Flat Epithelial Atypia of the Breast as a Predictor of Malignancy: A Digital Image-based Histopathologic Analysis. Williams PA, Djordjevic B, Ayroud Y, Islam S, Gravel D, Robertson SJ, Parra-Herran C. Anal Quant Cytopathol Histpathol. (December 2014), 36(6): 305-13.

14. Frequency of Malignancy at Final Excision in Biopsy-diagnosed Benign Papillary Lesions of the Breast. Petkiewitz, S and Islam, S (author of correspondence). Can J Pathol. (Fall 2013), 5(3): Pages 89-95.

15. Co-expression and Cellular Localization of P16 (INK 4a) and Mib1 (Ki-67) Help in Differentiating High Grade Squamous Intraepithelial Lesions from Immature Squamous Metaplasia of the Uterine Cervix. Amin MS, Senterman M, Islam S (author of correspondence). Can J Pathol, (Winter 2011), Volume 3, Issue 4, Pages 20-27.

16. Breast Cancer 1 (BRCA1) Protein Expression as a Prognostic Marker in Sporadic Epithelial Ovarian Carcinoma: an NCIC CTG OV.16 Correlative Study.
Weberpals JI, Tu D, Squire JA, Amin MS, Islam S, Pelletier LB, O'Brien AM, Hoskins PJ, Eisenhauer EA. Annals of Oncology, Volume 22, Issue 11, (November 2011), Pages 2403–2410, https://doi.org/10.1093/annonc/mdq770

17. Cadherin-catenin Protein Expression Profile in Ovarian Neoplasms. S Amin and S. Islam (author of correspondence). European Journal of Cancer 48(6): 64, (November 2012), DOI: 10.1016/S0959-8049(12 )72010-5.

18. Repression of Cancer Cell Senescence by PKCi. Paget JA, Restall IJ, Daneshmand M, Mersereau JA, Simard M, Parolin DAE, Lavictoire S J, Amin MS, Islam S, Lorimer IAJ. Oncogene. (August 2012) Volume 2(31), Pages 3584-3596.

19. BRCA1 protein levels and PI3KA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis. Hilton JF, Amin MS, Daneshmand M, Weberpals JI, Lorimer I, Islam S, Mallick R, Kanji F, Hopkins S, Verma S. Oncology Letters, 4(1), 141-145, 2012.

20. Immunocytochemical Study of Urine Cytological Preparations from Secondary Prostatic Adenocarcinoma Involving the Urinary Bladder. K. T. Mai, I. Itrat, S. J. Robertson, E. C. Belanger, J. Veinot and S. Islam (author of correspondence). Diagn Cytopathol. (2008 Oct), 36(10):715-20. doi: 10.1002/dc.20886.

21. Atypical Squamous Cells, Cannot Exclude High Grade Squamous Intraepithelial Lesion, ASC-H: Cytohisto correlation and Diagnostic Pitfalls. G. Mokhtar, N. Dilatour, A. Assiri, M. Gilliat, M. Senterman and S. Islam (author of correspondence). Acta Cytol. (2008 Mar-Apr), 52(2):169-77.

22. Cytologic Features of Benign Solitary Pulmonary Nodules with Radiologic Correlation and Diagnostic Pitfalls: A Report of Six Cases. Shahidul Islam (author of correspondence), NL Delatour Roustan, Shafeeq R Salahdeen, Kien T Mai, Mary Senterman, Ghadeer A Mokhtar. Acta Cytol. (2009), Volume 53, Issue 2, Pages 201-210.

23. Progesterone Receptor in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. K. T. Mai, I. Teo, E. C. Belanger, S. Robertson, E. C. Marginean and S. Islam. Histopathology. (2008 Feb); 52(3): 277-82.

24. Fine Needle Aspiration of Biopsy for Pre-operative work of Pancreatic Cystic Neoplasm: Report of 4 Cases. N. R. Delatour, M. C. Policarpio-Nicolas, H. Yazdi, S. Islam (author of correspondence). Acta Cytol. (Nov-Dec 2007), 51(6):925-33.

25. Reprocessing of Unsatisfactory Thin Prep Specimens Increases Specimen Adequacy and Detection of Significant Abnormal Cervicovaginal Lesions. S. Islam (1st author), A. M. West, H. Saboorian and R. Ashfaq. Cancer Cytopath. (2004 April 25), 102(2): 67-73.

26. Fine Needle Aspiration Cytology of Collecting Duct Carcinoma of the Kidney: Distinctive features and Differential Diagnosis. V. R. Sarode, S. Islam (1st author), D. Wooten, K. Molberg and R. Ashfaq. Acta Cytol. (2004), 48(6): 843-8.

27. Urinary Obstruction in a 78- Year-Old-Woman with A Pelvic Mass (a Case of Brenner Tumor and Literature review). G. Gannon, S. Islam, R. Conley and A. Zaher. Archives of Pathology & Laboratory Medicine: (September 2003), Vol. 127, No. 9, pp. 1225-1226.

28. A 29-Year-Old Male with Intermittent Lower Leg Pain. (A Case of Ewing Sarcoma and Literature Review). S. Islam (1st author), R. Conley and A. Zaher. Archives of Pathology & Laboratory Medicine: (July 2003), Vol. 127, No. 7, pp. e311-e312.

29. A 30-Year-Old-Man with Recurrent Pneumonia (a Case of Lung Sequestration and Literature Review). L. Shope, S. Islam and A. Zaher. Archives of Pathology & Laboratory Medicine: May 2002, Vol. 126, No. 5, pp. 623-624.

30. A 48-Year-Old White Woman with a Nodular Mass in the Right Parotid Gland (a Case of Malignant Lymphoma in Parotid Gland and Literature Review). T. Sheridan, S. Islam, and A. Zaher. Archives of Pathology & Laboratory Medicine: (February 2001), Vol. 125, No. 2, pp. 295-296.

31. Deep Venous Thrombosis in a 21- Year-Old Woman with a Retroperitoneal Mass (a Case of Malignant Peripheral Nerve Sheath Tumor and Literature Review). G. Gelickman, S. Islam, and A. Zaher. Archives of Pathology & Laboratory Medicine: (November 2000), Vol. 124, No. 11, pp. 1728-1730.

32. A Case of Systemic Mastocytosis (Literature Review). Islam, S. (author of correspondence), and Zaher, A. Archives of Pathology & Laboratory Medicine: (April 2000), Vol. 124, No. 4, pp. 645-645.

33. Vimentin Expression in Human Carcinoma Cell: Relationship with Phenotypic Changes and Cadherin Based Cell Adhesion. Islam, S (1st author), Wheelock, M. J., and Johnson, K. R. J. Cell. Biochem, (2000) 78(1): 141-150.

34. N-cadherin Extracellular Repeat 4 Mediates Epithelial to Mesenchymal Transition and Increased Motility. Jae-Kim, Islam, Young J. Kim, Ryan S. Prudoff, Kristin M. Sass, Wheelock, M. J., and Johnson, K. R.
J. Cell Biol. (2000) 151(6): 1193-1206.

35. Expression of N-Cadherin by Human Squamous Carcinoma Cells Induces a Scattered Fibroblastic Phenotype with Disrupted Cell-to-Cell Adhesion. Islam, S (1st author), Carey, T. E., Wolf, G. T., Wheelock, M. J., and Johnson, K. R. J. Cell. Biol. (1996) 135(6) 1643-1654.

Peer reviewed commentaries from the Cytopathology Scientific Committee at the Institute of Quality Management in Healthcare (IQMH) at https://iqmh.org/
(14- peer-reviewed publications)

36. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1401. Z. Ghorab, M. Weir, S. Islam (senior author), S. McRae and D. Kuni

37. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1405. S. Islam (1st author), M. Weir, Z. Ghorab, D. Kuni and S. McRae

38. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO 1409-PP (patterns-of-practice). M. Weir, S. Islam (senior author), Z. Ghorab, D. Kuni and S. McRae

39. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys-CYTO-1501. S. Islam (1st author), M. Weir, Z. Ghorab, E. Ecobichon-Morris and S. McRae

40. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1505. S. Islam (1st author), M. Weir, Z. Ghorab, E. Ecobichon-Morris and S. McRae

41. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1601. Z. Ghorab, M. Weir, S. Islam (senior author), E. Ecobichon-Morris and S. McRae

42. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1605. S. Islam (1st author), M. Weir, Z. Ghorab, E. Ecobichon-Morris and S. McRae

43. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1610-PP (patterns-of-practice). M. Weir, S. Islam (senior author), Z. Ghorab, E. Ecobichon-Morris and S. McRae

44. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1701. S. Islam (1st author), Z. Ghorab, C.Zeman-Pocrnich, S. McRae, E. Ecobichon-Morris

45. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1705. Z. Ghorab, S. Islam (senior author), C.Zeman-Pocrnich, S. McRae, E. Ecobichon-Morris and S. McRae

46. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1801. C. Zeman-Pocrnich, S. Islam (senior author), Z. Ghorab, S. McRae, E. Ecobichon-Morris

47. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1805. Z. Ghorab, S. Islam (senior author), C.Zeman-Pocrnich, E. Ecobichon-Morris and S. McRae

48. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1809-PP (patterns-of-practice). C.Zeman-Pocrnich, S. Islam (senior author), Z. Ghorab, S. McRae, E. Ecobichon-Morris

49. Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1901-NG. Z. Ghorab, S. Islam (senior author), C.Zeman-Pocrnich, E. Ecobichon-Morris and S. McRae

50. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-Published PATH-2101 Oversight, Iron, Von Kossa, Congo Red

51. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)- PATH-2103 ER, PR, HER2 IHC, HER2 ISH, E-Cadherin

52. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2105 CD117, DOG1, GMS, PAS (Fungal)

53. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)PATH-2106 CD68, CD34, SMA, SMM-H

54. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2109 SOX10, S-100, Masson Fontana, Trichrome

55. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2202 ER, PR, HER2 IHC, HER2 ISH, Cytokeratin 5/6

56. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2205 Synaptophysin, Chromogranin, Oversight, Calcium

57. Pathology Scientific Committee Comment, Institute of Quality Management in Healthcare (IQMH)-PATH-2206 P16, Vimentin, PAX8, WT1

58. Consensus Practice Recommendation – Gynecologic and Non-Gynecologic Cytology, 2015. S. Islam (1st author), Z. Ghorab, C.Zeman-Pocrnich, S. McRae, E. Ecobichon-Morris

External Expert Review of Practice Guidelines, Program in Evidence-Based Care (PEBC-CCO), Canadian Society of Cytopathology (CSC) and Ontario Medical Association (OMA) and College of Physicians and Surgeons of Ontario (CPSO) (10)

59. Best Practice Recommendation Guidelines for Gynecologic and Non-Gynecologic Cytopathology (Institute of Quality Management in Healthcare, IQMH).

60. Best Practice Recommendation for Standards2Cytology document (an initiative by OMA and CPSO).

61. EBS 26-3Evidence-Based Series 26-3IN REVIEWA Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO)Follow-up and Surveillance of Curatively Treated Lung Cancer Patients.

62. Evidence-Based Series #1-19A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Locoregional Therapy of Locally Advanced Breast Cancer (LABC).

63. Evidence-Based Series #15-12Version 2A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) The Organization of Colposcopy Services in Ontario: Recommended Framework

64. Guideline 4-3 Version 4A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Systemic Therapy for Recurrent Epithelial Ovarian Cancer.

65. Evidence -Based Series #7-13-2v2 Recommendations for Prophylactic Cranial Irradiation and Consolidative Radiation for Patients with Small Cell Lung Cancer: Endorsement: 2019 National Institute for Health and Care Excellence.

66. Evidence-guideline #7-A-2018-2 Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO and CCO Joint Clinical Practice Guideline Update.

67. Evidence-Based Guideline # 7-A-2018-3 Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Peer Reviewed Electronic Learning Modules Institute of Quality Management and Healthcare (IQMH) at https://iqmh.org/

68. FNA Neck Mass; 48-Year Old Male. Shahidul Islam, Zeina Ghorab, Michele Weir, Anne Ecobichon-Morris, Susan McRae.
https://iqmh.org/Portals/0/Docs/Services/eLearn_Labs/e-Learn%20LAB%20-%20CYTO%201801.
pdf (January, 2018)

69. Anal Pap 47-Year-Old Male; HIV-Seropositive. Zeina Ghorab, Shahidul Islam, Michele Weir, Susan McRae and Anne Ecobichon-Morris.
https://iqmh.org/Portals/0/Docs/Services/eLearn_Labs/e-Learn%20LAB%20-%20CYTO%201701.
pdf (January, 2017).

70. Pap, Liquid-based 42-Year Old Female. Michele Weir, Zeina Ghorab, Shahidul Islam, Ms. Anne Ecobichon-Morris, Susan McRae.
https://iqmh.org/Portals/0/Docs/Services/eLearn_Labs/e-Learn%20LAB%20-%20CYTO%201705.
pdf (May, 2017)

Book Chapters at https://www.pathologyoutlines.com
Completed chapters as Primary Author (43)

1. Ovary - nontumor - Large solitary luteinized follicular cyst of pregnancy and puerperium - 1 Jun 2012
2. Ovary - nontumor - Massive edema of ovary - 1 Jun 2012
3. Ovary - nontumor - Polycystic ovary disease (PCO) - 1 Jun 2012
4. Ovary - nontumor - Pregnancy luteoma - 1 Jun 2012
5. Ovary - nontumor - Rete ovarii cyst - 1 May 2012
6. Ovary - nontumor - Stromal hyperplasia and hyperthecosis - 1 May 2012
7. Ovary - nontumor - Torsion - 1 May 2012
8. Thyroid gland - Fibromatosis/fasciitis-like variant - 1 Mar 2009
9. Thyroid gland - Autoimmune thyroiditis - 1 Mar 2009
10. Thyroid gland - Bethesda guidelines for cytology: Malignant - 1 Jul 2014
11. Thyroid gland - Clear cell change - 1 Mar 2009
12. Thyroid gland - Diffuse follicular variant - 1 Mar 2009
13. Thyroid gland - Encapsulated follicular variant - 1 Mar 2009
14. Thyroid gland - Focal lymphocytic thyroiditis - 1 Mar 2009
15. Thyroid gland - Frozen section - 1 Mar 2009
16. Thyroid gland - Hashimoto thyroiditis - 1 Mar 2009
17. Thyroid gland - Hashimoto's thyroiditis - Fibrous (fibrosing) variant - 1 Mar 2009
18. Thyroid gland - Histology - 1 Mar 2009
19. Thyroid gland - Infectious thyroiditis - 1 Mar 2009
20. Thyroid gland - Infectious thyroiditis - Tuberculous thyroiditis - 2 Mar 2009
21. Thyroid gland - Insular carcinoma - Poorly differentiated carcinoma with rhabdoid features - 2 Mar 2009
22. Thyroid gland - Lithium thyroiditis - 1 Mar 2009
23. Thyroid gland - Macrofollicular variant - 1 Mar 2009
24. Thyroid gland - Mixed medullary-follicular tumors - 1 Mar 2009
25. Thyroid gland - Palpation thyroiditis - 1 Mar 2009
26. Thyroid gland - Papillary carcinoma - follicular variant - 1 Mar 2009
27. Thyroid gland - papillary carcinoma: cytology - 1 Mar 2009
28. Thyroid gland - Physiology - 1 Mar 2009
29. Thyroid gland - Post-partum thyroiditis - 2 Mar 2009
30. Thyroid gland - Postoperative necrotizing granulomas - 1 Mar 2009
31. Thyroid gland - Radiation thyroiditis (radiation induced changes) - 1 Mar 2009
32. Thyroid gland - Riedel thyroiditis - 1 Mar 2009
33. Thyroid gland - Rosai-Dorfman disease - 1 Mar 2009
34. Thyroid gland - SARS related changes - 1 Mar 2009
35. Thyroid gland - Silent thyroiditis - 1 Mar 2009
36. Thyroid gland - Solid variant - 1 Mar 2009
37. Thyroid gland - Solitary papillary hyperplastic nodule - 1 Mar 2009
38. Thyroid gland - Subacute thyroiditis - 1 Mar 2009
39. Thyroid gland - Suspicious for malignancy - 1 Jun 2014
40. Thyroid gland - Thyroid cancer - General - 1 Mar 2009
41. Thyroid gland - Thyroid cancer in children - 1 Mar 2009
42. Thyroid gland - toxic goiter - 1 Mar 2009
43. Thyroid gland - Warthin-like variant - 1 Mar 2009

Cancer; Endometrial cancer; Lung cancer; Ovarian cancer; Thyroid cancer